Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
Share
The office coordinates nationwide testing of new treatment approaches for cancer.
Season 1 Episode 10 - Dr. Meg Mooney, Associate Director of CTEP, NCI
0:0018:16
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
Inside FedRAMP 20x: GSA’s Pete Waterman Talks Speed, Security
FedRAMP 20x is transforming federal cloud authorizations. GSA’s Pete Waterman shares how automation and continuous monitoring are speeding approvals and strengthening security.
24m watch -
VA’s Platform One Offers Sandbox to Software Developers
Platform One’s sandbox environment allows developers to create applications in protected conditions, keeping veteran data safe and secure.
14m watch -
GAO’s Advice for Bolstering Federal Cybersecurity
Federal agencies face persistent challenges in implementing cybersecurity best practices, but shifting culture, refining hiring practices and enforcing stronger requirements can drive long-term resilience.
10m listen -
AI is Helping Navy Track Global Maritime Activity
NRL is using AI to analyze over 400 million daily data points to monitor global vessel activity and flag potential threats.
17m watch
